Trials / Conditions / Systemic Vasculitis

Systemic Vasculitis

15 registered clinical trials studyying Systemic Vasculitis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune NCT07037732	Centre Hospitalier Universitaire de Nice	—
Enrolling By Invitation	Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases NCT06763783	Region Skane	Phase 4
Recruiting	Rare AutoImmune SElf-management Programme Development NCT06642870	University of the West of England	—
Unknown	COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases NCT05236491	Paul R Fortin	Phase 2 / Phase 3
Unknown	Study of Refractory and/or Relapsing TAkayasu aRTeritis NCT03543527	Assistance Publique - Hôpitaux de Paris	—
Unknown	Acquired Immunodeficiency in ANCA Associated Vasculitis NCT03514979	Cambridge University Hospitals NHS Foundation Trust	Phase 2
Completed	Journey of Patients With Vasculitis From First Symptom to Diagnosis NCT03410290	University of Pennsylvania	—
Completed	Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease NCT03762824	Region Skane	Phase 4
Recruiting	Vasculitis Pregnancy Registry NCT02593565	University of Pennsylvania	—
Terminated	Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis NCT02556866	Assistance Publique - Hôpitaux de Paris	Phase 2
Completed	Impact of Vasculitis on Employment and Income NCT02476292	University of South Florida	—
Completed	Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiS NCT02042092	Hospital of Southern Norway Trust	N/A
Terminated	Resistance Exercise in Rheumatic Disease NCT01599260	Johns Hopkins University	N/A
Terminated	GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases NCT01257802	Joseph Mccune	Phase 3
Unknown	Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases NCT01151644	University of Sao Paulo	Phase 4